• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Device Problem Complete Blockage (1094)
Patient Problem Occlusion (1984)
Event Date 02/03/2020
Event Type  Injury  
Manufacturer Narrative
Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following information was reported to gore: in an article titled "short-term outcomes of the t-branch off-the-shelf multibranched stent graft for reintervention after previous infrarenal aortic repair" it states the following: a retrospective two-center study was undertaken.All consecutive patients who underwent endovascular repair using t-branch stent graft after previous infrarenal aortic repair between january 2010 and august 2018 were included.Demographics, past medical history, cardiovascular risk factors, and intraoperative and perioperative details were recorded.Technical success and early (30-day) mortality, morbidity, target vessel patency, and presence of endoleak were analyzed.During the first year of follow-up, survival, freedom from reintervention, and patency rates were recorded.Gore® viabahn® endoprostheses and gore® viabahn® vbx balloon expandable endoprostheses were used as branch grafts in the study as well as non-gore devices.One patient developed target artery instability (type ic endoleak) at the distal branch attachment of the superior mesenteric artery stent that had been bridged using a gore® viabahn® endoprosthesis.This led to a reintervention.(reported separately pt.434-1).Additionally, three target vessels occluded at 12 months post implant: 1 celiac artery (reported separately pt.434-3), 1 superior mesenteric artery (reported separately pt.434-2), 1 right renal artery (this report-pat.434-4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
heidi inskeep
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key10388374
MDR Text Key203106519
Report Number2017233-2020-01102
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
P40037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,litera
Reporter Occupation Physician
Type of Report Initial
Report Date 08/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/10/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/14/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age74 YR
-
-